MyAverix Finance
NS · Healthcare
Oxygenta Pharmaceutical Ltd (524636)
Pharmaceuticals & Biotechnology
Oxygenta Pharmaceutical Ltd (524636) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.78B, P/E ratio is -10.11, net margin is -11.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 524636
Oxygenta Pharmaceutical Ltd (524636) — FAQ
What is Oxygenta Pharmaceutical Ltd's market cap?
Oxygenta Pharmaceutical Ltd (524636) has a reported market cap of $1.78B (data as of 2026-07-10).
What is 524636's P/E ratio?
The price-to-earnings (P/E) ratio for Oxygenta Pharmaceutical Ltd (524636) is -10.11 (data as of 2026-07-10).
Does Oxygenta Pharmaceutical Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Oxygenta Pharmaceutical Ltd (524636). Check the MyAverix Finance app for the latest dividend data.
What sector is Oxygenta Pharmaceutical Ltd in?
Oxygenta Pharmaceutical Ltd (524636) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 524636 listed on?
524636 is listed on NS.
What is Oxygenta Pharmaceutical Ltd's net margin?
Oxygenta Pharmaceutical Ltd (524636) reports a net margin of -11.2% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.